| First Author | Collazo J | Year | 2014 |
| Journal | Cancer Res | Volume | 74 |
| Issue | 8 | Pages | 2362-73 |
| PubMed ID | 24509905 | Mgi Jnum | J:210536 |
| Mgi Id | MGI:5571418 | Doi | 10.1158/0008-5472.CAN-13-3058 |
| Citation | Collazo J, et al. (2014) Cofilin drives cell-invasive and metastatic responses to TGF-beta in prostate cancer. Cancer Res 74(8):2362-73 |
| abstractText | Cofilin (CFL) is an F-actin-severing protein required for the cytoskeleton reorganization and filopodia formation, which drives cell migration. CFL binding and severing of F-actin is controlled by Ser3 phosphorylation, but the contributions of this step to cell migration during invasion and metastasis of cancer cells are unclear. In this study, we addressed the question in prostate cancer cells, including the response to TGF-beta, a critical regulator of migration. In cells expressing wild-type CFL, TGF-beta treatment increased LIMK-2 activity and cofilin phosphorylation, decreasing filopodia formation. Conversely, constitutively active CFL (SerAla) promoted filipodia formation and cell migration mediated by TGF-beta. Notably, in cocultures of prostate cancer epithelial cells and cancer-associated fibroblasts, active CFL promoted invasive migration in response to TGF-beta in the microenvironment. Further, constitutively active CFL elevated the metastatic ability of prostate cancer cells in vivo. We found that levels of active CFL correlated with metastasis in a mouse model of prostate tumor and that in human prostate cancer, CFL expression was increased significantly in metastatic tumors. Our findings show that the actin-severing protein CFL coordinates responses to TGF-beta that are needed for invasive cancer migration and metastasis. |
